Latest News and Press Releases
Want to stay updated on the latest news?
-
Sustained reactivation of mutant p53 drives durable anti-tumor activity across models, including KRAS co-mutant tumorsFMC-220 selectively stabilizes p53 Y220C at lower doses, overcoming key...
-
Dublin, April 24, 2025 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Market - A Global and Regional Analysis: Focus on Tissue Testing, Cancer Panel Type, Cancer Type, Application,...
-
Grand Cayman, Cayman Islands, April 23, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA...
-
Dublin, April 16, 2025 (GLOBE NEWSWIRE) -- The "Epigenetics Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
-
Dublin, April 15, 2025 (GLOBE NEWSWIRE) -- The "Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area...
-
Dublin, April 11, 2025 (GLOBE NEWSWIRE) -- The "Exosome Research Market by Product Type (Instruments & Software, Isolation Kits, Purification Kits), Method (Filtration, Microfluidics,...
-
Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Epigenetics Market Report 2025" has been added to ResearchAndMarkets.com's offering.The epigenetics market size has grown exponentially in recent...
-
Dublin, April 02, 2025 (GLOBE NEWSWIRE) -- The "Personalized Medicine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...
-
Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "Europe Hereditary Genetic Testing Market: Focus on Genetic Testing Type and Country - Analysis and Forecast, 2024-2033" report has been added to ...
-
Grand Cayman, Cayman Islands, March 28, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA...